Literature DB >> 3087976

Role of polycationic C-terminal portion in the structure and activity of recombinant human interferon-gamma.

T Arakawa, Y R Hsu, C G Parker, P H Lai.   

Abstract

Purified recombinant human interferon-gamma, produced in Escherichia coli, was digested with trypsin under mild conditions, resulting in a preparation containing approximately 90% of a Mr = 15,800 protein and 10% of a 14,400 protein. The Mr = 15,800 protein has an intact N terminus and the Mr = 14,400 protein lacks 14 N-terminal residues. Both proteins lack C terminus of approximately 13 residues. This preparation containing the Mr = 15,800 and 14,400 proteins was identical with the intact protein with respect to conformation and dimerization, as analyzed by circular dichroism and gel filtration. However, the antiviral activity of this preparation was 1000-fold lower than that of the intact molecule. Since the majority of this preparation is the Mr = 15,800 protein, these results suggest that the C terminus does not affect the protein conformation and self-association, but greatly alters antiviral activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3087976

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Use of synthetic peptides to identify an N-terminal epitope on mouse gamma interferon that may be involved in function.

Authors:  H I Magazine; J M Carter; J K Russell; B A Torres; B M Dunn; H M Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

2.  Proteolytic inactivation of cytokines by Pseudomonas aeruginosa.

Authors:  M Parmely; A Gale; M Clabaugh; R Horvat; W W Zhou
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  The antichlamydial, antiviral, and antiproliferative activities of human gamma interferon are dependent on the integrity of the C terminus of the interferon molecule.

Authors:  L M de la Maza; E M Peterson; L E Burton; P W Gray; E Rinderknecht; C W Czarniecki
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

4.  Posttranslational processing of recombinant human interferon-gamma in animal expression systems.

Authors:  D C James; M H Goldman; M Hoare; N Jenkins; R W Oliver; B N Green; R B Freedman
Journal:  Protein Sci       Date:  1996-02       Impact factor: 6.725

5.  Modulation of major histocompatibility complex protein expression by human gamma interferon mediated by cysteine proteinase-adhesin polyproteins of Porphyromonas gingivalis.

Authors:  P L Yun; A A DeCarlo; N Hunter
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  The limited proteolysis of tumor necrosis factor-alpha.

Authors:  L O Narhi; M F Rhode; P Hunt; T Arakawa
Journal:  J Protein Chem       Date:  1989-10

Review 7.  Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity.

Authors:  Elise Alspach; Danielle M Lussier; Robert D Schreiber
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-03-01       Impact factor: 10.005

8.  Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture.

Authors:  E M Curling; P M Hayter; A J Baines; A T Bull; K Gull; P G Strange; N Jenkins
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

9.  Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity.

Authors:  R T Horvat; M J Parmely
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

10.  Role of N-glycosylation in the synthesis, dimerization and secretion of human interferon-gamma.

Authors:  T Sareneva; J Pirhonen; K Cantell; N Kalkkinen; I Julkunen
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.